Global Cancer Stem Cells Market By Mode of Action (Targeted Cancerous Stem Cells (CSCs) (Anti-Cancer Stem Cell Therapeutics (Pathway Inhibitors (WNT Signaling Pathway, Notch Signaling Pathway, Hedgehog Signaling Pathway, and Others), Surface Marker-based, Nanoparticle-based Therapies, Immuno-evasion & Targeting Tumor Microenvironment, and Others) and Products (Molecular Analysis, Cell Separation, Cell Culturing, Cell Analysis, and Others)), Stem Cell-based Cancer Therapy (Autologous SC Transplant and Allogeneic SC Transplant)), By Cancer Type (Breast, Pancreatic, and Others), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034
- Published date: June 2025
- Report ID: 151453
- Number of Pages: 387
- Format:
-
keyboard_arrow_up
-
-
- STEMCELL Technologies.
- PromoCell GmbH
- Merck KGaA Company Profile
- Lonza Group AG Company Profile
- Gamida Cell
- FUJIFILM Irvine Scientific
- Calidi Biotherapeutics, Inc
- Bionomics
- settingsSettings
Our Clients
- 151453
- June 2025
Trusted by more than 17382 organizations globally
✖
Request a Sample Report
We'll get back to you as quickly as possible
|
Single User
$6,000
$3,999
USD / per unit
save 24%
|
Multi User
$8,000
$5,999
USD / per unit
save 28%
|
Corporate User
$10,000
$6,999
USD / per unit
save 32%
|
|
|---|---|---|---|
| e-Access | |||
| Report Library Access | |||
| Data Set (Excel) | |||
| Company Profile Library Access | |||
| Interactive Dashboard | |||
| Free Custumization | No | up to 10 hrs work | up to 30 hrs work |
| Accessibility | 1 User | 2-5 User | Unlimited |
| Analyst Support | up to 20 hrs | up to 40 hrs | up to 50 hrs |
| Benefit | Up to 20% off on next purchase | Up to 25% off on next purchase | Up to 30% off on next purchase |
| Buy Now ($ 3,999) | Buy Now ($ 5,999) | Buy Now ($ 6,999) |
